Portfolio company
BrainDTech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops a diagnostic platform using microRNA biomarkers from liquid biopsies for the early detection and monitoring of neurodegenerative diseases for healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Promental Health
Promental Health develops a blood test using microRNA biomarkers and machine learning for the early diagnosis of Alzheimer's disease for healthcare providers.
Neuronostics
The company develops an EEG-based digital biomarker platform to provide objective diagnostic and prognostic support for epilepsy to healthcare providers and pharmaceutical researchers.
Neurovision
This company provides diagnostic blood tests and retinal imaging software to help healthcare providers detect and monitor neurodegenerative diseases.
TAUDIA
Taudia develops blood-based protein biomarker detection kits and diagnostic instruments for researchers and clinicians to identify Alzheimer's and other neurodegenerative diseases.
Brainbox Solutions
The company develops AI-enabled diagnostic tests and biomarker panels to aid clinicians in diagnosing and predicting recovery for patients with mild traumatic brain injuries.
Pre Diagnostics
This company develops intracellular blood tests and biomarker analytical services for the early detection of Alzheimer's disease for patients, practitioners and researchers.
Circular Genomics
This company develops circular RNA blood tests for diagnosing neurological and psychiatric disorders for healthcare providers, researchers and pharmaceutical organisations.
ViewMind
ViewMind develops eye-tracking cognitive assessment tools for pharmaceutical researchers and healthcare providers to detect and monitor neurodegenerative diseases and brain health.
